Preconception Multi for Women 60 capsules Batch 42469 recalled
NRC Nutrition Pty Ltd is recalling Preconception Multi for Women 60 capsules, Batch 42469, due to inconsistent blending of iodine in the product.
The agency’s classification
FDA (Food): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA classified this as Class II. The source text does not report any illnesses or injuries and the hazard is inconsistent iodine blending in a dietary supplement, which represents a moderate labeling/quality control issue without reported adverse health consequences.
Plain-English summary
NRC Nutrition Pty Ltd is recalling Preconception Multi for Women 60 capsules in blister packs, Batch 42469, due to inconsistent blending of iodine in the product. The recalled product was distributed in Texas, Minnesota, California, Indiana, and Oklahoma.
Consumers who have purchased this product should stop using it and consult with their healthcare provider if they have any concerns.
The recalled product
- Product
- Preconception Multi for Women 60 capsules packaged in blister packs Batch 42469
- Manufacturer
- NRC Nutrition Pty Ltd
- Category
- Drug — Dietary Supplement
- Hazard
- Affected units
- 7
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Batch 42469
Distribution
Related recalls
Other drug recalls
- ModerateTeva Recalls Metoclopramide Tablets Due to Foreign Object Presence
FDA (Drugs) · 2026-10-21
- SevereHouston Rx LLC Recalls Tirzepatide/Niacinamide Vials Due to Sterility Concerns
FDA (Drugs) · 2026-10-21
- ModerateMetoclopramide Tablets Recalled Due to Presence of Foreign Tablets or Capsules
FDA (Drugs) · 2026-10-21
- ModerateHouston Rx LLC Recalls Sermorelin Vials Due to Process Control Issues
FDA (Drugs) · 2026-10-21
- SevereZydus Recalls Hydrocortisone Sodium Succinate Injection for Impurity Failures
FDA (Drugs) · 2026-10-21
Similar recalls
- SevereAIOS Synergy for Women Capsules recalled for undeclared milk
FDA (Food) · 2022-01-19
- High
- SevereAidapak Recalls Prenatal Multivitamin Tablets Due to Labeling Errors
FDA (Drugs) · 2014-01-22
- SevereAIOS Synergy for Men Capsules recalled for undeclared milk
FDA (Food) · 2022-01-19
- ModerateMegaFood Multi for Women 40+ Recalled for Missing Iron Warning
FDA (Food) · 2016-05-25
- High